KR102200656B1 - 마이크로스피어를 포함하는 개선된 창상 치료 조성물 - Google Patents

마이크로스피어를 포함하는 개선된 창상 치료 조성물 Download PDF

Info

Publication number
KR102200656B1
KR102200656B1 KR1020157009202A KR20157009202A KR102200656B1 KR 102200656 B1 KR102200656 B1 KR 102200656B1 KR 1020157009202 A KR1020157009202 A KR 1020157009202A KR 20157009202 A KR20157009202 A KR 20157009202A KR 102200656 B1 KR102200656 B1 KR 102200656B1
Authority
KR
South Korea
Prior art keywords
microspheres
wound
pharmaceutical composition
wounds
delete delete
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020157009202A
Other languages
English (en)
Korean (ko)
Other versions
KR20150082207A (ko
Inventor
블라디미르 리터
메리 클레이만
데보라 하나 바르트펠트
에일론 아스쿨라이
Original Assignee
폴리힐 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 폴리힐 리미티드 filed Critical 폴리힐 리미티드
Publication of KR20150082207A publication Critical patent/KR20150082207A/ko
Application granted granted Critical
Publication of KR102200656B1 publication Critical patent/KR102200656B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/745—Polymers of hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0014—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020157009202A 2012-09-13 2013-09-12 마이크로스피어를 포함하는 개선된 창상 치료 조성물 Active KR102200656B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261700362P 2012-09-13 2012-09-13
US61/700,362 2012-09-13
PCT/IL2013/050774 WO2014041543A1 (en) 2012-09-13 2013-09-12 Improved wound healing compositions comprising microspheres

Publications (2)

Publication Number Publication Date
KR20150082207A KR20150082207A (ko) 2015-07-15
KR102200656B1 true KR102200656B1 (ko) 2021-01-11

Family

ID=50277729

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020157009202A Active KR102200656B1 (ko) 2012-09-13 2013-09-12 마이크로스피어를 포함하는 개선된 창상 치료 조성물

Country Status (17)

Country Link
US (1) US9370533B2 (enExample)
EP (1) EP2895209B1 (enExample)
JP (1) JP6104390B2 (enExample)
KR (1) KR102200656B1 (enExample)
AU (1) AU2013316718B2 (enExample)
BR (1) BR112015005335B1 (enExample)
CA (1) CA2883455C (enExample)
DK (1) DK2895209T3 (enExample)
ES (1) ES2748805T3 (enExample)
HR (1) HRP20191804T1 (enExample)
HU (1) HUE047212T2 (enExample)
LT (1) LT2895209T (enExample)
MX (1) MX359713B (enExample)
PL (1) PL2895209T3 (enExample)
PT (1) PT2895209T (enExample)
RS (1) RS59410B1 (enExample)
WO (1) WO2014041543A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6893877B2 (ja) * 2014-10-29 2021-06-23 スペクトラル エムディー, インコーポレイテッドSpectral Md, Inc. 組織を分類するための反射モードマルチスペクトル時間分解型光学イメージングの方法および装置
WO2018160963A1 (en) 2017-03-02 2018-09-07 Spectral Md, Inc. Machine learning systems and techniques for multispectral amputation site analysis
JP7261883B2 (ja) 2018-12-14 2023-04-20 スペクトラル エムディー，インコーポレイテッド 創傷の評価、治癒予測および治療のための機械学習システム
KR102812782B1 (ko) 2018-12-14 2025-05-23 스펙트랄 엠디, 인크. 고정밀도 다중-애퍼쳐 스펙트럼 이미징을 위한 시스템 및 방법
US10783632B2 (en) 2018-12-14 2020-09-22 Spectral Md, Inc. Machine learning systems and method for assessment, healing prediction, and treatment of wounds
US10740884B2 (en) 2018-12-14 2020-08-11 Spectral Md, Inc. System and method for high precision multi-aperture spectral imaging
JP2024514493A (ja) 2021-03-30 2024-04-02 スペクトラル エムディー，インコーポレイテッド 多重化照明を利用したスナップショット型高精度マルチスペクトルイメージングシステムおよびその方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5614310A (en) 1994-11-04 1997-03-25 Minnesota Mining And Manufacturing Company Low trauma wound dressing with improved moisture vapor permeability
US5861149A (en) 1997-06-04 1999-01-19 Polyheal Ltd. Methods for wound treatment
EP1041970B1 (en) * 1998-10-23 2013-07-03 Polyheal Ltd. Compositions of microspheres for wound healing
MXPA03008109A (es) * 2001-03-07 2003-12-12 Pfizer Prod Inc Moduladores de la actividad de receptores de quimiocinas.
US7465463B2 (en) 2002-09-04 2008-12-16 Polyheal, Ltd. Compositions comprising microspheres with anti-inflammatory properties for healing of ocular tissues
WO2007089902A2 (en) * 2006-01-31 2007-08-09 David Vachon Compositions and methods for promoting the healing of tissue of multicellular organisms
GB0607774D0 (en) * 2006-04-20 2006-05-31 Renovo Group Plc Medicaments

Also Published As

Publication number Publication date
HRP20191804T1 (hr) 2019-12-27
LT2895209T (lt) 2019-10-25
ES2748805T3 (es) 2020-03-18
RS59410B1 (sr) 2019-11-29
US9370533B2 (en) 2016-06-21
PT2895209T (pt) 2019-10-28
HUE047212T2 (hu) 2020-04-28
BR112015005335A2 (pt) 2017-07-04
KR20150082207A (ko) 2015-07-15
EP2895209A1 (en) 2015-07-22
BR112015005335B1 (pt) 2020-03-10
MX359713B (es) 2018-10-08
JP2015528492A (ja) 2015-09-28
JP6104390B2 (ja) 2017-03-29
AU2013316718A1 (en) 2015-03-12
WO2014041543A1 (en) 2014-03-20
HK1212638A1 (en) 2016-06-17
CA2883455A1 (en) 2014-03-20
EP2895209A4 (en) 2016-04-20
PL2895209T3 (pl) 2020-01-31
AU2013316718B2 (en) 2016-09-29
EP2895209B1 (en) 2019-07-17
MX2015002816A (es) 2015-05-15
BR112015005335A8 (pt) 2018-01-30
US20150231170A1 (en) 2015-08-20
CA2883455C (en) 2020-01-28
DK2895209T3 (da) 2019-10-21

Similar Documents

Publication Publication Date Title
KR102132543B1 (ko) 양이온성 살생물제를 포함하는 페트롤라툼-계 조성물
Khorasani et al. Aloe versus silver sulfadiazine creams for second-degree burns: a randomized controlled study
AU2013316718B2 (en) Improved wound healing compositions comprising microspheres
JP6778219B2 (ja) 皮膚の炎症を抑制するイガイ接着タンパク質製品及びその適用
JP2021520373A (ja) Ｃｇｒｐを阻害する際に使用するための神経毒素
JP2019206544A (ja) 次亜塩素酸ナトリウムを含む抗炎症溶液
CN116531369A (zh) 一种化合物在促进伤口愈合药物中的应用
Serafini et al. Recent patents on medicinal plants/natural products as a therapeutic approach to wounds and burns healing
US20220249734A1 (en) Powdered collagen wound care compositions
EP3087990B1 (en) Gel-forming powder comprising sulfamonomethoxine and chitosan for treating wounds
RU2286781C2 (ru) Способ лечения химических ожогов пищевода у детей
RU2173155C1 (ru) Ранозаживляющий, противовоспалительный и противоинфекционный лекарственный препарат
HK1212638B (en) Improved wound healing compositions comprising microspheres
US20250367224A1 (en) Galactose and fucose monosaccharides for re-epithelialization and treating lesions
EP4659751A1 (en) Galactose and fucose monosaccharides for re-epithelialization and treating lesions
CN115245502B (zh) 滴喷剂型纳米脂质体凝胶三伏贴
CN112316108A (zh) 促进及治疗慢性伤口愈合的组合物和方法
KR101607229B1 (ko) 말기름을 함유하는 상처 치료용 조성물
KR102644156B1 (ko) 피부 상처 또는 화상 치료 작용제
US20260137839A1 (en) Controlled hydrogel delivery of focal adhesion kinase inhibitor for decreased scar formation
Katual et al. Advancements in Treatment of Laceration by Chitosan Coated Flexible Liposomes of Mupirocin: A current prospective
Sar Development and characterisation of metformin loaded film with flaxseed gel for acceleration of healing process of burn wounds: an approach for tissue regeneration
CN117617500A (zh) 一种适用于术后恢复的功能型配方粉及其制备方法和用法
Palácio et al. WOUND HEALING EFFECTS OF Β-LAPACHONE-LOADED LIPOSOMAL HYDROGEL BASED ON BACTERIAL CELLULOSE AND HYDROXYETHYLCELLULOSE

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20150409

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20180907

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20200213

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20201013

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20210105

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20210105

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20231228

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20241226

Start annual number: 5

End annual number: 5